StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.39−0.11 (-0.49%)

Close on Nov 18, 2026Market cap $455.87MP/E –Yield –

Assembly Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Assembly Biosciences's market cap was $444.05M on Nov 11, 2026, against $597.72M a year earlier. Over the last 5 years it ranged from $36.84M to $667.57M, with a median of $91.91M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$444.05M-17.5%
2025Dec 31, 2025$537.94M+436.5%
2024Dec 31, 2024$100.27M+132.4%
2023Dec 29, 2023$43.15M-31.5%
2022Dec 30, 2022$63.03M-42.5%
2021Dec 31, 2021$109.69M-44.9%
2020Dec 31, 2020$199.20M-62.4%
2019Dec 31, 2019$529.38M-8.1%
2018Dec 31, 2018$575.93M-26.8%
2017Dec 29, 2017$786.74M+275.9%
2016Dec 30, 2016$209.30M+61.8%
2015Dec 31, 2015$129.36M+89.4%
2014Dec 31, 2014$68.29M-13.5%
2013Dec 31, 2013$78.93M+182.5%
2012Dec 31, 2012$27.94M-71.9%
2011Dec 30, 2011$99.36M–

More Assembly Biosciences figures

See a number that looks wrong?